{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T13:14:12Z","timestamp":1719234852083},"reference-count":23,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Hip involvement in patients with spondyloarthritis is responsible for disability\nand functional impairment. Its treatment is not codified.\nOur study aimed to determine the associated factors with moderate and severe hip involvement in\nspondyloarthritis patients. It also aimed to assess the efficacy of tumour necrosis factor inhibitors\n(TNFi) on hip disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We conducted a cross-sectional study, including 44 spondyloarthritis patients with hip involvement.\nHip involvement was diagnosed based on radiographic findings. We assessed the following\nparameters: Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing\nSpondylitis Radiology Index (BASRI), patient global assessment (PGA), and Lequesne index. We\ncompared these parameters and the mean radiographic joint space width between the time of the\nstudy to those right before the use of TNFi.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Hip involvement was bilateral in 31 patients. The mean age was 44.56\u00b112.21 years. There\nwere 29 men. Severe and moderate involvement (BASRI-hip&gt;3) was reported in 21 hips from 75\naffected. These patients were older and had longer diagnosis delays than patients with BASRI-\nhip&lt;3. They had a higher body mass index and more limited spine mobility (BASMI). Functional\nhip impairment assessed by the Lequesne index was higher in these patients.\nTNFi prescribed in 23 patients with hip involvement, led to an improvement in the Lequesne index\n(12.75 vs 7.5, p: 0.001) and PGA (7 vs 2, p: 0.001). However, the mean joint space width remained\nunchanged (3.8 vs 3.7mm, p: 0.532).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion  :<\/jats:title>\n<jats:p>Our study showed that higher body mass and Lequesne indexes are associated with\nmoderate and severe hip involvement. TNFi may improve both the Lequesne index and PGA and\nstabilize the radiological findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397117666211012110212","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:09:19Z","timestamp":1634339359000},"page":"58-63","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Associated Factors with the Severity of Hip Involvement in Spondyloarthritis and Efficacy of TNF \u03b1 Inhibitors in these Patients"],"prefix":"10.2174","volume":"18","author":[{"given":"Maroua","family":"Slouma","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Military Hospital, Tunis, Tunisia | Tunis El Manar University, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Rahmouni","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Military Hospital, Tunis, Tunisia | Tunis El Manar University, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Dhahri","sequence":"additional","affiliation":[{"name":"Tunis El Manar University, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elhem","family":"Cheour","sequence":"additional","affiliation":[{"name":"Tunis El Manar University, Tunis, Tunisia | Pain Treatment Center, La Rabta Hospital, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Gharsallah","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Military Hospital, Tunis, Tunisia | Tunis El Manar University, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Metoui","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Military Hospital, Tunis, Tunisia | Tunis El Manar University, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Louzir","sequence":"additional","affiliation":[{"name":"Tunis El Manar University, Tunis, Tunisia | Department of Internal Medicine, Military Hospital, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"481","volume":"30","author":"Burki V.","year":"2012","unstructured":"Burki V.; Gossec L.; Payet J.; Durnez A.; Elhai M.; Fabreguet I.; Koumakis E.; Meyer M.; Paternotte S.; Roure F.; Dougados M.; Prevalence and characteristics of hip involvement in spondyloarthritis: a single-centre observational study of 275 patients. Clin Exp Rheumatol 2012,30(4),481-486","journal-title":"Clin Exp Rheumatol"},{"key":"ref=2","author":"Scaramangas-Plumley D.","year":"2016","unstructured":"Scaramangas-Plumley D.; Lee M.; Rahbar M.H.; Gensler L.S.; Reveille J.D.; Weisman M.;  Hip disease treatment and progression in ankylosing spondylitis 2016","journal-title":"Hip disease treatment and progression in ankylosing spondylitis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"Rudwaleit M.","year":"2009","unstructured":"Rudwaleit M.; van der Heijde D.; Landew\u00e9 R.; Listing J.; Akkoc N.; Brandt J.; Braun J.; Chou C.T.; Collantes-Estevez E.; Dougados M.; Huang F.; Gu J.; Khan M.A.; Kirazli Y.; Maksymowych W.P.; Mielants H.; S\u00f8rensen I.J.; Ozgocmen S.; Roussou E.; Valle-O\u00f1ate R.; Weber U.; Wei J.; Sieper J.; The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009,68(6),777-783","journal-title":"Ann Rheum Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"Rudwaleit M.","year":"2011","unstructured":"Rudwaleit M.; van der Heijde D.; Landew\u00e9 R.; Akkoc N.; Brandt J.; Chou C.T.; Dougados M.; Huang F.; Gu J.; Kirazli Y.; Van den Bosch F.; Olivieri I.; Roussou E.; Scarpato S.; S\u00f8rensen I.J.; Valle-O\u00f1ate R.; Weber U.; Wei J.; Sieper J.; The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011,70(1),25-31","journal-title":"Ann Rheum Dis"},{"key":"ref=5","first-page":"2866","volume":"27","author":"MacKay K.","year":"2000","unstructured":"MacKay K.; Brophy S.; Mack C.; Doran M.; Calin A.; The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol 2000,27(12),2866-2872","journal-title":"J Rheumatol"},{"key":"ref=6","first-page":"1694","volume":"21","author":"Jenkinson T.R.","year":"1994","unstructured":"Jenkinson T.R.; Mallorie P.A.; Whitelock H.C.; Kennedy L.G.; Garrett S.L.; Calin A.; Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994,21(9),1694-1698","journal-title":"J Rheumatol"},{"key":"ref=7","first-page":"2286","volume":"21","author":"Garrett S.","year":"1994","unstructured":"Garrett S.; Jenkinson T.; Kennedy L.G.; Whitelock H.; Gaisford P.; Calin A.; A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994,21(12),2286-2291","journal-title":"J Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"Lukas C.","year":"2009","unstructured":"Lukas C.; Landew\u00e9 R.; Sieper J.; Dougados M.; Davis J.; Braun J.; van der Linden S.; van der Heijde D.; Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009,68(1),18-24","journal-title":"Ann Rheum Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/03009748709102182","volume":"65","author":"Lequesne M.G.","year":"1987","unstructured":"Lequesne M.G.; Mery C.; Samson M.; Gerard P.; Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987,65,85-89","journal-title":"Scand J Rheumatol Suppl"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10067-013-2263-x","volume":"32","author":"Konsta M.","year":"2013","unstructured":"Konsta M.; Sfikakis P.P.; Bournia V.K.; Karras D.; Iliopoulos A.; Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol 2013,32(8),1229-1232","journal-title":"Clin Rheumatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3904\/kjim.2015.229","volume":"32","author":"Jeong H.","year":"2017","unstructured":"Jeong H.; Eun Y.H.; Kim I.Y.; Kim H.; Lee J.; Koh E-M.; Cha H.S.; Characteristics of hip involvement in patients with ankylosing spondylitis in Korea. Korean J Intern Med (Korean Assoc Intern Med) 2017,32(1),158-164","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=12","first-page":"1236","volume":"29","author":"Brophy S.","year":"2002","unstructured":"Brophy S.; Mackay K.; Al-Saidi A.; Taylor G.; Calin A.; The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002,29(6),1236-1243","journal-title":"J Rheumatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10067-013-2278-3","volume":"32","author":"Guan M.","year":"2013","unstructured":"Guan M.; Wang J.; Zhao L.; Xiao J.; Li Z.; Shi Z.; Management of hip involvement in ankylosing spondylitis. Clin Rheumatol 2013,32(8),1115-1120","journal-title":"Clin Rheumatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/rheumatology\/27.5.393","volume":"27","author":"Calin A.","year":"1988","unstructured":"Calin A.; Elswood J.; The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis--one disease process or several? Br J Rheumatol 1988,27(5),393-395","journal-title":"Br J Rheumatol"},{"key":"ref=15","first-page":"241","volume":"22","author":"Abu-Shakra M.","year":"1995","unstructured":"Abu-Shakra M.; Gladman D.D.; Thorne J.C.; Long J.; Gough J.; Farewell V.T.; Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome. J Rheumatol 1995,22(2),241-245","journal-title":"J Rheumatol"},{"key":"ref=16","first-page":"CD004800","author":"Chen J.","year":"2005","unstructured":"Chen J.; Liu C.; Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2005(2),CD004800","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jbspin.2018.01.006","volume":"85","author":"Wendling D.","year":"2018","unstructured":"Wendling D.; Lukas C.; Prati C.; Claudepierre P.; Gossec L.; Goupille P.; Hudry C.; Miceli-Richard C.; Molto A.; Pham T.; Saraux A.; Dougados M.; 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis. Joint Bone Spine 2018,85(3),275-284","journal-title":"Joint Bone Spine"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"71","author":"Ward M.M.","year":"2019","unstructured":"Ward M.M.; Deodhar A.; Gensler L.S.; Dubreuil M.; Yu D.; Khan M.A.; Haroon N.; Borenstein D.; Wang R.; Biehl A.; Fang M.A.; Louie G.; Majithia V.; Ng B.; Bigham R.; Pianin M.; Shah A.A.; Sullivan N.; Turgunbaev M.; Oristaglio J.; Turner A.; Maksymowych W.P.; Caplan L.; 2019 update of the american college of rheumatology\/spondylitis association of america\/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken) 2019,71(10),1285-1299","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/ard.2006.064543","volume":"66","author":"Vander Cruyssen B.","year":"2007","unstructured":"Vander Cruyssen B.; Ribbens C.; Boonen A.; Mielants H.; de Vlam K.; Lenaerts J.; Steinfeld S.; Van den Bosch F.; Dewulf L.; Vastesaeger N.; The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis 2007,66(8),1072-1077","journal-title":"Ann Rheum Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jbspin.2011.03.023","volume":"78","author":"Wang D.","year":"2011","unstructured":"Wang D.; Ma L.; Wu D.; Efficacy of etanercept in ankylosing spondylitis hip lesions. Joint Bone Spine 2011,78(5),531-532","journal-title":"Joint Bone Spine"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00296-011-1844-8","volume":"32","author":"Lian F.","year":"2012","unstructured":"Lian F.; Yang X.; Liang L.; Xu H.; Zhan Z.; Qiu Q.; Ye Y.; Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. Rheumatol Int 2012,32(6),1663-1667","journal-title":"Rheumatol Int"},{"key":"ref=22","first-page":"339","volume":"76","author":"Petrov A.","year":"2017","unstructured":"Petrov A.; Zayaeva H.; Petrov A.; THU0355\u2005Influence of adalimumab and sulfasalazine on structure of hyaline cartilage of hip joints in patients with ankylosing spondilitis. Ann Rheum Dis 2017,76(Suppl. 2),339-339","journal-title":"Ann Rheum Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3899\/jrheum.161401","volume":"44","author":"Song R.","year":"2017","unstructured":"Song R.; Chung S.W.; Lee S-H.; Radiographic evidence of hip joint recovery in patients with ankylosing spondylitis after treatment with anti-tumor necrosis factor agents: a case series. J Rheumatol 2017,44(11),1759-1760","journal-title":"J Rheumatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397117666211012110212","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197182\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397117666211012110212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:24:33Z","timestamp":1656581073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197182\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397117666211012110212","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}